Gofen & Glossberg LLC IL reduced its stake in Colgate-Palmolive Company (NYSE:CL) by 3.4% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 160,080 shares of the company’s stock after selling 5,663 shares during the period. Gofen & Glossberg LLC IL’s holdings in Colgate-Palmolive were worth $11,716,000 as of its most recent SEC filing.

A number of other hedge funds also recently made changes to their positions in the company. Chickasaw Capital Management LLC raised its stake in shares of Colgate-Palmolive by 218.3% in the first quarter. Chickasaw Capital Management LLC now owns 16,920 shares of the company’s stock valued at $1,238,000 after buying an additional 11,605 shares in the last quarter. Meritage Portfolio Management raised its stake in shares of Colgate-Palmolive by 0.3% in the first quarter. Meritage Portfolio Management now owns 95,879 shares of the company’s stock valued at $7,017,000 after buying an additional 255 shares in the last quarter. ProShare Advisors LLC raised its stake in shares of Colgate-Palmolive by 9.9% in the first quarter. ProShare Advisors LLC now owns 879,652 shares of the company’s stock valued at $64,382,000 after buying an additional 79,323 shares in the last quarter. Geneva Advisors LLC raised its stake in shares of Colgate-Palmolive by 2.5% in the first quarter. Geneva Advisors LLC now owns 18,051 shares of the company’s stock valued at $1,321,000 after buying an additional 438 shares in the last quarter. Finally, Hartford Financial Management Inc. raised its stake in shares of Colgate-Palmolive by 1.1% in the first quarter. Hartford Financial Management Inc. now owns 4,800 shares of the company’s stock valued at $351,000 after buying an additional 50 shares in the last quarter. 73.15% of the stock is currently owned by institutional investors and hedge funds.

Colgate-Palmolive Company (CL) traded down 0.47% during mid-day trading on Friday, hitting $71.30. 2,132,416 shares of the stock traded hands. Colgate-Palmolive Company has a 1-year low of $63.43 and a 1-year high of $77.27. The stock has a market cap of $62.80 billion, a price-to-earnings ratio of 26.50 and a beta of 0.80. The company’s 50 day moving average price is $71.78 and its 200-day moving average price is $73.27.

Colgate-Palmolive (NYSE:CL) last released its earnings results on Friday, July 21st. The company reported $0.72 EPS for the quarter, hitting analysts’ consensus estimates of $0.72. Colgate-Palmolive had a net margin of 15.83% and a return on equity of 3,121.95%. The company had revenue of $3.83 billion for the quarter, compared to analysts’ expectations of $3.89 billion. During the same quarter last year, the business earned $0.70 EPS. The firm’s revenue was down .5% compared to the same quarter last year. Analysts predict that Colgate-Palmolive Company will post $2.89 earnings per share for the current year.

The company also recently announced a quarterly dividend, which was paid on Tuesday, August 15th. Shareholders of record on Tuesday, July 18th were paid a dividend of $0.40 per share. This represents a $1.60 dividend on an annualized basis and a yield of 2.24%. The ex-dividend date of this dividend was Friday, July 14th. Colgate-Palmolive’s payout ratio is 59.48%.

COPYRIGHT VIOLATION WARNING: This piece of content was posted by TheOlympiaReport and is the sole property of of TheOlympiaReport. If you are reading this piece of content on another domain, it was copied illegally and reposted in violation of international copyright laws. The legal version of this piece of content can be accessed at https://theolympiareport.com/2017/09/02/gofen-glossberg-llc-il-decreases-stake-in-colgate-palmolive-company-cl.html.

CL has been the topic of several research reports. Bank of America Corporation lifted their price objective on shares of Colgate-Palmolive from $78.00 to $80.00 and gave the stock a “buy” rating in a research report on Wednesday, May 31st. Zacks Investment Research lowered shares of Colgate-Palmolive from a “hold” rating to a “sell” rating in a research report on Thursday, July 27th. Jefferies Group LLC reaffirmed a “hold” rating and issued a $79.00 price objective on shares of Colgate-Palmolive in a research report on Thursday, August 24th. Vetr lowered shares of Colgate-Palmolive from a “buy” rating to a “hold” rating and set a $76.67 price objective on the stock. in a research report on Wednesday, May 17th. Finally, Royal Bank Of Canada reaffirmed a “hold” rating and issued a $74.00 price objective on shares of Colgate-Palmolive in a research report on Thursday, May 25th. Two analysts have rated the stock with a sell rating, twelve have given a hold rating and two have issued a buy rating to the company’s stock. Colgate-Palmolive presently has an average rating of “Hold” and a consensus target price of $75.82.

In other Colgate-Palmolive news, COO Justin Skala sold 74,374 shares of the firm’s stock in a transaction that occurred on Thursday, July 27th. The shares were sold at an average price of $72.51, for a total transaction of $5,392,858.74. Following the sale, the chief operating officer now owns 97,177 shares in the company, valued at approximately $7,046,304.27. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, insider Patricia Verduin sold 3,833 shares of the firm’s stock in a transaction that occurred on Tuesday, August 15th. The stock was sold at an average price of $71.45, for a total transaction of $273,867.85. Following the sale, the insider now owns 53,173 shares in the company, valued at approximately $3,799,210.85. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 221,802 shares of company stock worth $15,983,976. 1.02% of the stock is owned by company insiders.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive Company (NYSE:CL).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive Company and related companies with Analyst Ratings Network's FREE daily email newsletter.